Dr. Rajesh Banderudrappagari, MD
- Medicare services, 2024
- 871
- Medicare patients, 2024
- 280
- Part D claims, 2024
- 1,711
- Publications
- 2
- MIPS score, 2024
- 82
- Practice address
- 3850 S National Ave, Springfield, MO 65807
- Practice phone
- Call (417) 875-3000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Coxhealth Medical Oncology
Springfield, Missouri
Find Dr. Banderudrappagari's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Rajesh Banderudrappagari is a hematologist and oncologist in Springfield, Missouri
Dr. Banderudrappagari practices at Coxhealth Medical Oncology in Springfield, Missouri.
Dr. Banderudrappagari's NPI, 1093094260, was assigned on August 5, 2011. Dr. Banderudrappagari holds Illinois license 036142066.
- NPI
- 1093094260NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3173849742
- NPI enumeration date
- August 5, 2011
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (417) 875-3000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 50
- Medical school graduation
- 2002
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Rajesh Banderudrappagari practices at Coxhealth Medical Oncology in Springfield, Missouri
Dr. Banderudrappagari's primary practice is Coxhealth Medical Oncology, at 3850 S National Ave, Springfield, MO 65807 in Greene County. The practice phone is (417) 875-3000.
- Coxhealth Medical Oncology3850 S National Ave, Springfield, MO 65807 · Greene CountyPhone(417) 875-3000
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Rajesh Banderudrappagari is affiliated with 7 sites of care and 1 medical group
Dr. Banderudrappagari's primary practice is Coxhealth Medical Oncology in Springfield, Missouri. Dr. Banderudrappagari is also affiliated with Mercy Hospital Springfield. The medical group on file is CoxHealth Neurology. Dmand AI also links Dr. Banderudrappagari to 3 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Rajesh Banderudrappagari's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Banderudrappagari practices, 6 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Coxhealth Medical Oncology | Available with a free account |
| +6 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Rajesh Banderudrappagari is one of 187 hematologists and oncologists in Missouri
Hematology and oncology is Dr. Banderudrappagari's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Banderudrappagari is licensed in Illinois.
Specialties and state licenses
- Hematology and oncology, IllinoisPrimary
Hematologists and oncologists near Dr. Banderudrappagari
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Rajesh Banderudrappagari billed Medicare for 871 services in 2024
CMS data shows 871 Medicare services from Dr. Banderudrappagari across 9 procedure codes in 2024, for 280 Medicare patients. Medicare paid $64,104 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Banderudrappagari's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 8792024: 8592%
- Other services
- 2023: 02024: 12
- Surgery
- 2023: 372024: 0100%
Dr. Banderudrappagari compared with the Missouri median for hematologists and oncologists, 2024
- Dr. Banderudrappagari
- Missouri median
- Medicare services
- 871vs 73019% above
- Medicare patients
- 280vs 272Close to median
- Part D claims
- 1,442vs 5512.6 times
Medians across 185 hematologists and oncologists in Missouri with Dmand AI profiles that report each measure.
Dr. Banderudrappagari's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Banderudrappagari?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Banderudrappagari and other hematologists and oncologists in Missouri.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Rajesh Banderudrappagari treated 280 Medicare patients in 2024, average age 74
CMS counts 280 Medicare patients who saw Dr. Banderudrappagari in 2024. The largest group is 65 to 74, with 120 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Banderudrappagari's median patient age at 73, with 57% women.
Dr. Banderudrappagari's Medicare patients by age, 2024
Dr. Banderudrappagari's Medicare patients by sex, 2024
- Women14753%
- Men13348%
Chronic conditions among Dr. Banderudrappagari's Medicare patients, 2024
- High blood pressure75%
- High cholesterol67%
- Arthritis55%
- Cancer48%
- Chronic kidney disease35%
- Diabetes32%
- COPD30%
- Anxiety28%
Share of Medicare patients with each condition. A patient can have several.
Dr. Banderudrappagari's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 73
Patient panel by sex, all payers
- Women57%
- Men43%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Rajesh Banderudrappagari wrote 1,711 Medicare Part D claims in 2024
In 2024, Dr. Banderudrappagari wrote 1,711 Medicare Part D claims for 251 patients. 84% of them were for generic drugs. CMS names the drug for 1,442 of them, across 39 drugs with 11 or more claims each, at $2,660,056 in total drug cost. In 2023, CMS named 1,085 claims across 27 drugs.
Dr. Banderudrappagari's Part D claims by kind of drug, 2024
- Generic1,432 claims84%
- Brand-name279 claims16%
Dr. Banderudrappagari's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Banderudrappagari's Part D claims, 2024
- Opioids11%181 of 1,711 claims
- Antibiotics3%47 of 1,711 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,0852024: 1,44233%
Drugs named by CMS: 39 in 2024, 27 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Rajesh Banderudrappagari scored 82 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Banderudrappagari for performance year 2024, reported as part of a group. Dr. Banderudrappagari accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Banderudrappagari's MIPS scores, performance year 2024
- 82of 100Final score
- 61.6of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 77of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Rajesh Banderudrappagari has 2 publications on record
Dmand AI links 2 papers to Dr. Banderudrappagari in 2019. Dr. Banderudrappagari's most frequent co-authors are Matthew Blake Lockwood, MD and Issam Makhoul, MD.
Dr. Banderudrappagari's most frequent co-authors
Recent publications by Dr. Banderudrappagari
Am Fam Physician
See who Dr. Banderudrappagari researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Banderudrappagari works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Rajesh Banderudrappagari received $875 in industry payments from 2019 to 2025
CMS Open Payments shows 43 general payments to Dr. Banderudrappagari from 14 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 98% of the total. Celgene Corporation paid the most, $242.
General payments to Dr. Banderudrappagari by program year, 2019 to 2025
General payments to Dr. Banderudrappagari by kind, 2019 to 2025
- Food and beverage$86198%
- Education$142%
Companies that paid Dr. Banderudrappagari the most, 2019 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Rajesh Banderudrappagari's profile data
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Rajesh Banderudrappagari
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Rajesh Banderudrappagari's NPI number?
Dr. Rajesh Banderudrappagari's NPI number is 1093094260. It was assigned on August 5, 2011, and it is active in the NPI Registry.
What kind of doctor is Dr. Rajesh Banderudrappagari?
Dr. Rajesh Banderudrappagari is a hematologist and oncologist in Springfield, Missouri. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Rajesh Banderudrappagari practice?
Dr. Banderudrappagari practices at 3850 S National Ave, Springfield, MO 65807. Dr. Banderudrappagari's primary practice is Coxhealth Medical Oncology in Springfield, Missouri. Dmand AI also links Dr. Banderudrappagari to 3 hospitals, 1 group practice or clinic and 1 home health agency.
What is Dr. Rajesh Banderudrappagari's office phone number?
The practice phone on file for Dr. Banderudrappagari is (417) 875-3000.
What is Dr. Rajesh Banderudrappagari's medical license number?
Dr. Banderudrappagari holds Illinois license 036142066.
Which hospitals is Dr. Rajesh Banderudrappagari affiliated with?
Dr. Banderudrappagari is affiliated with Mercy Hospital Springfield. Dmand AI links Dr. Banderudrappagari to 3 more hospitals.
What medical group is Dr. Rajesh Banderudrappagari part of?
Dr. Banderudrappagari is linked to CoxHealth Neurology.
Does Dr. Rajesh Banderudrappagari accept Medicare?
Yes. CMS data shows Dr. Banderudrappagari billed Medicare for 871 services in 2024, and Dr. Banderudrappagari accepts Medicare assignment.
What is Dr. Rajesh Banderudrappagari's MIPS score?
Dr. Banderudrappagari's MIPS final score for performance year 2024 is 82 out of 100, reported as part of a group.
How many Medicare patients does Dr. Rajesh Banderudrappagari see?
CMS counts 280 Medicare patients who saw Dr. Banderudrappagari in 2024, with an average age of 74.
Show 6 more questionsShow fewer questions
What services does Dr. Rajesh Banderudrappagari bill to Medicare?
In 2024, Dr. Banderudrappagari's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and office visit, established patient (99213).
What drugs does Dr. Rajesh Banderudrappagari prescribe most?
In 2024 Medicare Part D data, Dr. Banderudrappagari's most prescribed drugs by claims were Anastrozole, Letrozole and Ondansetron HCl.
Has Dr. Rajesh Banderudrappagari received payments from drug or device companies?
CMS Open Payments shows $875 in general payments to Dr. Banderudrappagari from 14 companies from 2019 to 2025. The largest total came from Celgene Corporation.
How long has Dr. Rajesh Banderudrappagari been practicing?
Dr. Banderudrappagari graduated from medical school in 2002, 24 years ago.
Does Dr. Rajesh Banderudrappagari do research?
Dmand AI links 2 publications to Dr. Banderudrappagari.
Who does Dr. Rajesh Banderudrappagari publish with?
Dr. Banderudrappagari's most frequent co-authors are Matthew Blake Lockwood, MD (1 shared paper) and Issam Makhoul, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in Missouri by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card